Showing results (31-40 of 185) with videos related to
Sort By:
Pageof 19
Canada Communicable Disease Report = Releve Des Maladies Transmissibles Au Canada|October 25, 2019
Updates to the Canadian Notifiable Disease Surveillance System and its interactive websiteS Totten, A Medaglia, S McDermottJournal of Immunology (Baltimore, Md. : 1950)|November 2, 2011
Quantifying antigen-specific CD4 T cells during a viral infection: CD4 T cell responses are larger than we thinkDaniel S McDermott, Steven M VargaArthritis Care and Research : the Official Journal of the Arthritis Health Professions Association|December 1, 1989
Family stress and coping in rheumatoid arthritisM J Foxall, C Kollasch, S McDermottResearch in Developmental Disabilities|April 13, 1999
Program evaluation of a sex education curriculum for women with mental retardationS McDermott, M Martin, M Weinrich, et al.International Urogynecology Journal and Pelvic Floor Dysfunction|October 31, 1998
Bladder tumor markers: need, nature and application. 1. Nucleus-based markersM M Kirollos, S McDermott, R A BradbrookProceedings. Symposium on Computer Applications in Medical Care|January 1, 1991
Effects of computerized nurse careplanning on selected health care effectiveness measuresL S Keller, S McDermott, A Alt-WhiteThe Nursing Clinics of North America|July 26, 2024
Setting Learners up for Simulation and Clinical Success: Achieving Psychological SafetyDonna S McDermott, Samantha Smeltzer, Jessica L KamererNature Reviews. Urology|April 14, 2011
Sustained response of adenocarcinoma of the urinary bladder to FOLFOX plus bevacizumabMinyuen Teo, Niall C Swan, Ray S McDermottInternational Urogynecology Journal and Pelvic Floor Dysfunction|October 31, 1998
Bladder tumor markers: need, nature and application. 2. Tumor and tumor-associated antigensM M Kirollos, S McDermott, R A BradbrookBritish Journal of Urology|July 1, 1997
The performance characteristics of the bladder tumour antigen testM M Kirollos, S McDermott, R A BradbrookPageof 19